Acadia Pharma Q2 2024 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
4 months ago
- Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q2 earnings results on Tuesday, August 6th, after market close.
- The consensus EPS Estimate is $0.18 and the consensus Revenue Estimate is $235.66M (+42.6% Y/Y).
- Over the last 3 months, EPS estimates have seen 4 upward revisions and 9 downward. Revenue estimates have seen 2 upward revisions and 14 downward.